Articles by Disease (Waldenstrom's Macroglobulinemia)

The Role of B Cell Receptor Stimulation in CLL Pathogenesis

Journal: Current Pharmaceutical Design
Volume: 18
Page: 3335-3355
Author(s): Laurens P. Kil, Saravanan Yuvaraj, Anton W. Langerak and Rudi W. Hendriks

Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates

Journal: Current Pharmaceutical Design
Volume: 17
Page: 3753-3771
Author(s): Petr Heneberg

Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia

Journal: Current Cancer Drug Targets
Volume: 11
Page: 1025-1029
Author(s): A. Sacco, I. M. Ghobrial and A. M. Roccaro

Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials

Journal: Current Cancer Drug Targets
Volume: 11
Page: 254-284
Author(s): G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar

Epidemiology and Management of Infectious Complications in Contemporary Management of Chronic Leukemias

Journal: Infectious Disorders - Drug Targets
Volume: 11
Page: 3-10
Author(s): Jo-Anne H. Young

Systems Biology of Apoptosis and Survival: Implications for Drug Development

Journal: Current Pharmaceutical Design
Volume: 17
Page: 190-203
Author(s): Salvatore Pezzino, Sabrina Paratore and Sebastiano Cavallaro

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Journal: Current Cancer Drug Targets
Volume: 10
Page: 716-727
Author(s): R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer